Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
Status: Recruiting
Location: See all (13) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The objective of this post-marketing surveillance (PMS) study is to assess the safety and effectiveness of CRYSVITA injection 10, 20, and 30mg, equivalent to in routine clinical settings
Eligibility
Participation Requirements
Sex: All
Minimum Age: 1 day
View:
• Patients who have been started on CRYSVITA® in accordance with the approved label in Korea
• Those (or his/her legal guardian) who have agreed in writing to participate in the survey. Children who have obtained a written consent of his/her legal guardian about participation in this survey. In case of pediatric patient, explain sufficiently what you think the patient can understand. In this case, the legal guardian may provide supplementary explanations of the survey.
Locations
Other Locations
Republic of Korea
Inje University Busan Paik Hospital
RECRUITING
Busan
Pusan National University Hospital
RECRUITING
Busan
Chonnam National University Hospital
RECRUITING
Gwangju
Chungnam National University Sejong Hospital
RECRUITING
Sejong
Korea University Guro Hospital
RECRUITING
Seoul
Seoul National University Hospital
RECRUITING
Seoul
Seoul National University Hospital
RECRUITING
Seoul
Seoul National University Hospital
RECRUITING
Seoul
Severance Hospital
RECRUITING
Seoul
Severance Hospital
RECRUITING
Seoul
Ajou University Hospital
RECRUITING
Suwon
Wonju Severance Christian Hospital
RECRUITING
Wŏnju
Yangsan Pusan National University Hospital
RECRUITING
Yangsan
Contact Information
Primary
HaeMi Park
haemi.park.m8@kyowakirin.com
+82-10-3378-3471
Time Frame
Start Date: 2023-08-11
Estimated Completion Date: 2031-07-16
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Kyowa Kirin Korea Co., Ltd.